Vecabrutinib manufacturers
- Vecabrutinib
-
- $79.00
-
2026-07-27
- CAS:1510829-06-7
- Purity: 99.74%
- Supply Ability: 10g
|
| | Vecabrutinib Basic information |
| Product Name: | Vecabrutinib | | Synonyms: | Vecabrutinib;[1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3R,3'R,4'S)-;Vecabrutinib(SNS-062);(3R,3'R,4'S)-1'-(6-Amino-5-fluoropyrimidin-4-yl)-3-((3-chloro-5-(trifluoromethyl)phenyl)amino)-2-oxo-[1,3'-bipiperidine]-4'-carboxamide;Vinflunine Impurity 11;Vecabrutinib, 10 mM in DMSO | | CAS: | 1510829-06-7 | | MF: | C22H24ClF4N7O2 | | MW: | 529.92 | | EINECS: | | | Product Categories: | | | Mol File: | 1510829-06-7.mol |  |
| | Vecabrutinib Chemical Properties |
| Boiling point | 776.0±60.0 °C(Predicted) | | density | 1.509±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 125 mg/mL (235.88 mM) | | form | Solid | | pka | 16.01±0.40(Predicted) | | color | White to light yellow |
| | Vecabrutinib Usage And Synthesis |
| Uses | Vecabrutinib is used in biological studies of Burton’s Tyrosine Kinase (BTK) inhibitors. | | in vivo | Vecabrutinib has good oral bioavailability in rat and dog (%F ≥ 40%) and a terminal half-life of 5 to 6 hours. Vecabrutinib is well tolerated with continuous drug levels and at exposures much greater than those achieved for PCI-32765[1]. |
| | Vecabrutinib Preparation Products And Raw materials |
|